Esther12
Senior Member
- Messages
- 13,774
In the BMJ:
http://www.bmj.com/content/357/bmj.j2782
Scihub: http://sci-hub.cc/http://www.bmj.com/content/bmj/357/bmj.j2782.full.pdf
Paul Glasziou is one of the co-authors of the planned Cochrane review of IPD for exercise trials for CFS.
They do have:
[Can't copy/paste easily - but it talks about need for transparency on psych/exercise trials.]
Related More Trials blog with comment from Goldacre underneath:
http://moretrials.net/news-research...ncy-also-makes-much-harder-randomised-trials/
Thought it could be of some interest to others. I found the blog pretty irritatin, but it is past my bed-time.
Focus on sharing individual patient data distracts from other ways of improving trial transparency
BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2782 (Published 22 June 2017) Cite this as: BMJ 2017;357:j2782
- Tammy Hoffmann, professor1,
- Paul Glasziou, professor1,
- Elaine Beller, associate professor1,
- Ben Goldacre, senior clinical research fellow2,
- Iain Chalmers, coordinator3
http://www.bmj.com/content/357/bmj.j2782
Scihub: http://sci-hub.cc/http://www.bmj.com/content/bmj/357/bmj.j2782.full.pdf
Paul Glasziou is one of the co-authors of the planned Cochrane review of IPD for exercise trials for CFS.
They do have:
All trials for all interventions
[Can't copy/paste easily - but it talks about need for transparency on psych/exercise trials.]
Related More Trials blog with comment from Goldacre underneath:
http://moretrials.net/news-research...ncy-also-makes-much-harder-randomised-trials/
Thought it could be of some interest to others. I found the blog pretty irritatin, but it is past my bed-time.